Omicron Aps company information, Employees & Contact Information

SARS-CoV-2 vaccine-induced antibodies protect against Omicron breakthrough infection ScienceDirect.com

Omicron, Delta, Alpha, and More: What To Know About the Coronavirus Variants Yale Medicine

Enhancing response to Omicron SARS-CoV-2 variant World Health Organization (WHO)

Omicron: 10 things to know about the very contagious COVID-19 variant University of California - Davis Health

Omicron is supercharging the COVID vaccine booster debate Nature

Protection against the Omicron Variant from Previous SARS-CoV-2 Infection The New England Journal of Medicine

Study: Most People Infected With Omicron Didn’t Know It Cedars-Sinai

Omicron and its Subvariants: A Guide to What We Know Yale Medicine

SARS-CoV-2 Omicron-B.1.1.529 leads to widespread escape from neutralizing antibody responses ScienceDirect.com

Update on Omicron World Health Organization (WHO)

Computationally restoring the potency of a clinical antibody against Omicron Nature

A Bivalent Omicron-Containing Booster Vaccine against Covid-19 The New England Journal of Medicine

One year since the emergence of COVID-19 virus variant Omicron World Health Organization (WHO)

SARS-CoV-2 Omicron variant replication in human bronchus and lung ex vivo Nature

Classification of Omicron (B.1.1.529): SARS-CoV-2 Variant of Concern World Health Organization (WHO)

Cellular immune breadth of an Omicron-specific, self-amplifying monovalent mRNA vaccine booster for COVID-19 Nature

Emergence of SARS-CoV-2 Omicron lineages BA.4 and BA.5 in South Africa Nature

Statement on Omicron sublineage BA.2 World Health Organization (WHO)

Broadly potent spike-specific human monoclonal antibodies inhibit SARS-CoV-2 Omicron sub-lineages Nature

TAG-VE statement on Omicron sublineages BQ.1 and XBB World Health Organization (WHO)

Considerable escape of SARS-CoV-2 Omicron to antibody neutralization Nature

Omicron escapes the majority of existing SARS-CoV-2 neutralizing antibodies Nature

Household transmission of SARS-CoV-2 Omicron variant of concern subvariants BA.1 and BA.2 in Denmark Nature

Imprinted SARS-CoV-2 humoral immunity induces convergent Omicron RBD evolution Nature

Attenuated fusogenicity and pathogenicity of SARS-CoV-2 Omicron variant Nature

Nirmatrelvir Use and Severe Covid-19 Outcomes during the Omicron Surge The New England Journal of Medicine

Striking antibody evasion manifested by the Omicron variant of SARS-CoV-2 Nature

What You Need to Know About XBB.1.5, the Latest Omicron Variant Johns Hopkins Bloomberg School of Public Health

Broadly neutralizing antibodies overcome SARS-CoV-2 Omicron antigenic shift Nature

Altered TMPRSS2 usage by SARS-CoV-2 Omicron impacts infectivity and fusogenicity Nature

Third BNT162b2 Vaccination Neutralization of SARS-CoV-2 Omicron Infection The New England Journal of Medicine

Effects of Previous Infection and Vaccination on Symptomatic Omicron Infections The New England Journal of Medicine

The latest on COVID-19’s omicron variant: What’s changed? MD Anderson Cancer Center

Antibody evasion properties of SARS-CoV-2 Omicron sublineages Nature

T cell responses to SARS-CoV-2 spike cross-recognize Omicron Nature

Effectiveness of mRNA-1273 against SARS-CoV-2 Omicron and Delta variants Nature

Household transmission of the SARS-CoV-2 Omicron variant in Denmark Nature

Covid-19 Vaccine Effectiveness against the Omicron (B.1.1.529) Variant The New England Journal of Medicine

BNT162b2 Protection against the Omicron Variant in Children and Adolescents The New England Journal of Medicine

SARS-CoV-2 Omicron is an immune escape variant with an altered cell entry pathway Nature

Genomic assessment of invasion dynamics of SARS-CoV-2 Omicron BA.1 Science | AAAS

Episode #63 - Omicron variant World Health Organization (WHO)

Spike and nsp6 are key determinants of SARS-CoV-2 Omicron BA.1 attenuation Nature

Durability of XBB.1.5 Vaccines against Omicron Subvariants The New England Journal of Medicine

Efficacy of Antiviral Agents against Omicron Subvariants BQ.1.1 and XBB The New England Journal of Medicine

Modeling transmission of SARS-CoV-2 Omicron in China Nature

The Omicron Booster: Your Questions Answered Yale Medicine

SARS-CoV-2 Omicron virus causes attenuated disease in mice and hamsters Nature

Investigation of a SARS-CoV-2 B.1.1.529 (Omicron) Variant Cluster — Nebraska, November–December 2021 | MMWR Centers for Disease Control and Prevention | CDC (.gov)

Protection by a Fourth Dose of BNT162b2 against Omicron in Israel The New England Journal of Medicine

Effectiveness of BNT162b2 Vaccine against Omicron Variant in South Africa The New England Journal of Medicine

Omicron: increased transmissibility and decreased pathogenicity Nature

Seroprevalence and infection fatality rate of the SARS-CoV-2 Omicron variant in Denmark: A nationwide serosurveillance study The Lancet

SARS-CoV-2 B.1.1.529 (Omicron) Variant — United States, December 1–8, 2021 Centers for Disease Control and Prevention | CDC (.gov)

The Omicron variant: what we need to know emro.who.int

Risk of long COVID associated with delta versus omicron variants of SARS-CoV-2 The Lancet

Omicron SARS-CoV-2 variant: a new chapter in the COVID-19 pandemic The Lancet

The P132H mutation in the main protease of Omicron SARS-CoV-2 decreases thermal stability without compromising catalysis or small-molecule drug inhibition | Cell Research Nature

Rapid epidemic expansion of the SARS-CoV-2 Omicron variant in southern Africa Nature

Dynamics of competing SARS-CoV-2 variants during the Omicron epidemic in England Nature

Risk of hospitalisation associated with infection with SARS-CoV-2 omicron variant versus delta variant in Denmark: an observational cohort study The Lancet

Risk of hospitalisation associated with infection with SARS-CoV-2 omicron variant versus delta variant in Denmark: an observational cohort study The Lancet

What we know about the Omicron variant Unicef

ATAGI recommendations on use of the Moderna and Pfizer monovalent Omicron XBB.1.5 COVID-19 vaccines Australian Government Department of Health, Disability and Ageing

First UK cases of Omicron variant identified GOV.UK